Tower Research Capital LLC (TRC) - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$128,803
+49.6%
7,722
+147.7%
0.00%
+33.3%
Q2 2023$86,119
+226528.9%
3,118
+88.1%
0.00%
+200.0%
Q1 2023$38
+100.0%
1,658
-5.1%
0.00%0.0%
Q4 2022$19
-100.0%
1,747
-93.6%
0.00%
-75.0%
Q3 2022$229,000
-42.9%
27,154
-46.5%
0.00%
-55.6%
Q2 2022$401,000
+174.7%
50,723
+720.4%
0.01%
+800.0%
Q1 2022$146,000
-51.7%
6,183
-30.0%
0.00%
-80.0%
Q4 2021$302,000
+40.5%
8,835
-27.2%
0.01%0.0%
Q3 2021$215,000
+133.7%
12,133
+493.0%
0.01%
+150.0%
Q2 2021$92,000
+130.0%
2,046
+32.3%
0.00%
+100.0%
Q1 2021$40,000
-82.2%
1,547
-86.2%
0.00%
-85.7%
Q4 2020$225,000
+765.4%
11,171
+735.5%
0.01%
Q3 2020$26,000
-49.0%
1,337
-53.7%
0.00%
-100.0%
Q2 2020$51,000
+155.0%
2,888
-0.4%
0.00%0.0%
Q4 2019$20,000
+1900.0%
2,899
+3765.3%
0.00%
Q2 2019$1,000
-97.9%
75
-98.9%
0.00%
-100.0%
Q4 2018$48,000
+4700.0%
7,128
+5790.9%
0.00%
Q3 2018$1,000
-85.7%
121
-88.4%
0.00%
Q2 2018$7,000
-36.4%
1,047
-19.1%
0.00%
-100.0%
Q1 2018$11,000
-64.5%
1,294
-26.1%
0.00%
-66.7%
Q3 2017$31,0001,7500.00%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2017$9,0006560.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$19,373,0004.95%
Bain Capital Life Sciences Investors, LLC 2,260,572$17,881,0002.10%
Finepoint Capital LP 735,126$5,815,0002.01%
Altium Capital Management LP 365,100$2,888,0001.16%
RTW INVESTMENTS, LP 4,794,499$37,924,0000.98%
Amitell Capital Pte Ltd 50,129$397,0000.90%
COWEN AND COMPANY, LLC 1,065,724$8,430,0000.81%
Tri Locum Partners LP 155,000$1,226,0000.50%
BVF INC/IL 1,106,838$8,755,0000.42%
HighVista Strategies LLC 46,459$367,0000.22%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders